Patent classifications
C
C12
C12N
2720/00
C12N2720/00011
C12N2720/12011
C12N2720/12111
C12N2720/12151
C12N2720/12152
C12N2720/12152
REOVIRIDAE VACCINE
The invention relates to an isolated African horse sickness virus (AHSV) ssRNA comprising a plurality of mutations; a complementary cell for replication of a vaccinal viral strain from said ssRNA; a vaccinal viral strain derived from said ssRNA; use of said vaccinal viral strain and/or isolated ssRNA in the vaccination of an animal against an infection by AHSV; a method of vaccination comprising same; and a pharmaceutical composition comprising said vaccinal viral strain and/or said isolated ssRNA.